Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
SKAN Group AG ( (CH:SKAN) ) has provided an update.
At its Annual General Meeting, SKAN Group AG received approval for all board proposals, including a dividend distribution of CHF 0.40 per share. The re-election of board members and approval of compensation and non-financial reports were also confirmed, reflecting strong shareholder support and stability in leadership.
More about SKAN Group AG
SKAN is a pioneer in aseptic and aseptic-toxic manufacturing processes for the (bio-)pharmaceutical industry, specializing in high-quality isolator systems for drug filling under strict sterility standards. The company also provides process support, services, and consumables, serving pharmaceutical and biotech industries, CMOs, and research labs globally. Founded in 1968, SKAN employs around 1,500 people, with a significant presence in the Life Sciences Hub of Basel and subsidiaries across various countries.
Average Trading Volume: 13,533
Current Market Cap: CHF1.54B
Learn more about SKAN stock on TipRanks’ Stock Analysis page.